Topical antimicrobial therapy for treating chronic wounds

Clinical Infectious Diseases

Volumn 49, Issue 10, 2009, Pages 1541-1549

  Lipsky, Benjamin A ^a   Hoey, Christopher ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACITRACIN; CADEXOMER IODINE; CETRIMIDE; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; CLINDAMYCIN; FUSIDIC ACID; GENTAMICIN; GRAMICIDIN; HEXACHLOROPHENE; HEXACHOLORPHENE; HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; IODINE DERIVATIVE; MAFENIDE ACETATE; METRONIDAZOLE; NEOMYCIN; PENICILLIN DERIVATIVE; POLYMYXIN; POVIDONE IODINE; PSEUDOMONIC ACID; RETAPAMULIN; SILVER NITRATE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; BURN; CHRONIC WOUND; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; WOUND DRESSING; WOUND INFECTION;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; HUMANS; WOUND INFECTION;

EID: 72849131465     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/644732     Document Type: Review

References (50)

1. Selwyn S. Microbial interactions and antibiosis. In: Maibach H, Aly R, eds. Skin microbiology: relevance to clinical infection. New York: Springer-Verlag, 1981:63-74.
2. Davies CE, Hill KE, Newcombe RG, et al. A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs. Wound Repair Regen 2007; 15:17-22.
3. Howell-Jones RS, Wilson MJ, Hill KE, Howard AJ, Price PE, Thomas DW. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 2005; 55:143-149
4. Tammelin A, Lindholm C, Hambraeus A. Chronic ulcers and antibiotic treatment. J Wound Care 1998; 7:435-437
5. White RJ, Cutting K, Kingsley A. Topical antimicrobials in the control of wound bioburden. Ostomy Wound Manage 2006; 52:26-58.
6. Cutting KF, White RJ. Criteria for identifying wound infection-revisited. Ostomy Wound Manage 2005; 51:28-34.
7. Heinzelmann M, Scott M, Lam T. Factors predisposing to bacterial invasion and infection. Am J Surg 2002; 183:179-190 (Pubitemid 34246432) (Pubitemid 34246432)
8. Gardner SE, Frantz RA, Doebbeling BN. The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen 2001; 9:178-186
9. Moore Z, Cowman S. Effective wound management: identifying criteria for infection. Nurs Stand 2007; 21:68, 70, 72.
10. Gardner SE, Hillis S, Frantz R. Clinical signs of infection in diabetic foot ulcers with high microbial load. Biol Res Nurs 2009; 11:119-128
11. White RJ, Cutting KF. Critical colonization-the concept under scrutiny. Ostomy Wound Manage 2006; 52:50-56
12. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen 2008; 16:37-44.
13. Davies CE, Hill KE, Wilson MJ, et al. Use of 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis for analysis of the microfloras of healing and nonhealing chronic venous leg ulcers. J Clin Microbiol 2004; 42:3549-3557
14. Frank DN, Wysocki A, Specht-Glick DD, et al. Microbial diversity in chronic open wounds. Wound Repair Regen 2009; 17:163-172
15. Rhoads DD,Wolcott RD, Percival SL. Biofilms in wounds:management strategies. J Wound Care 2008; 17:502-508
16. Drosou A, Falabella A, Kirsner R. Antiseptics on wounds: an area of controversy. Wounds 2003; 15(5). Available at http://www.medscape.com/ viewarticle/456300. Accessed 7 October 2009.
17. Lio PA, Kaye ET. Topical antibacterial agents. Infect Dis Clin North Am 2004; 18:717-733
18. Gelmetti C. Local antibiotics in dermatology. Dermatol Ther 2008; 21: 187-195
19. Patel PP, Vasquez SA, Granick MS, Rhee ST. Topical antimicrobials in pediatric burn wound management. J Craniofac Surg 2008; 19:913-922
20. Lineaweaver W, Howard R, Soucy D, et al. Topical antimicrobial toxicity. Arch Surg 1985; 120:267-270
21. Cooper RA. Iodine revisited. Int Wound J 2007; 4:124-137
22. Fonder MA, Lazarus GS, Cowan DA, Aronson-Cook B, Kohli AR, Mamelak AJ. Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol 2008; 58:185-206.
23. Castellano JJ, Shafii SM, Ko F, et al. Comparative evaluation of silvercontaining antimicrobial dressings and drugs. Int Wound J 2007; 4: 114-122
24. Molan PC. Honey as a topical antibacterial agent for treatment of infected wounds. World Wide Wounds 2001; November. Available at http://www.worldwidewounds.com/2001/november/Molan/honey-as-topical-agent.html. Accessed 7 October 2009.
25. Kwakman PH, Van den Akker JP, Guclu A, et al. Medical-grade honey kills antibiotic-resistant bacteria in vitro and eradicates skin colonization. Clin Infect Dis 2008; 46:1677-1682 (Pubitemid 351706764) (Pubitemid 351706764)
26. Molan PC, Cooper RA. Honey and sugar as a dressing for wounds and ulcers. Trop Doct 2000; 30:249-250 (Pubitemid 30775818)
27. Cooper RA, Molan PC, Harding KG. The sensitivity to honey of grampositive cocci of clinical significance isolated from wounds. J Appl Microbiol 2002; 93:857-863
28. Gonzalez-Espinosa D, Perez-Romano L, Guzman-Soriano B, Arias E, Bongiovanni CM, Gutierrez AA. Effects of pH-neutral, super-oxidised solution on human dermal fibroblasts in vitro. Int Wound J 2007; 4: 241-250
29. Goretti C, Mazzurco S, Nobili LA, et al. Clinical outcomes of wide postsurgical lesions in the infected diabetic foot managed with 2 different local treatment regimes compared using a quasi-experimental study design: a preliminary communication. Int J Low ExtremWounds 2007; 6:22-27 (Pubitemid 46247833) (Pubitemid 46247833)
30. Zahumensky E. Infections and diabetic foot syndrome in field practice. Vnitr Lek 2006; 52:411-416 (Pubitemid 43844849)
31. Kaehn K. Dermacyn on the infected foot ulcers of 10 patients. JWound Care 2007; 16:232.
32. Ulvatne H. Antimicrobial peptides: potential use in skin infections. Am J Clin Dermatol 2003; 4:591-595 (Pubitemid 37108418) (Pubitemid 37108418)
33. Reddy KV, Yedery RD, Aranha C. Antimicrobial peptides: premises and promises. Int J Antimicrob Agents 2004; 24:536-547
34. Ge Y, MacDonald D, Hait H, Lipsky B, Zasloff M, Holroyd K. Microbiological profile of infected diabetic foot ulcers. Diabet Med 2002; 19:1032-1034 (Pubitemid 35471974)
35. Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H, Zasloff M. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother 1999; 43:782-788
36. Lipsky BA. Pexiganan acetate [commentary]. Drugs 1999; 56:1053.
37. Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 2008; 47:1537-1545
38. Paul JC, Pieper BA. Topical metronidazole for the treatment of wound odor: a review of the literature. Ostomy Wound Manage 2008; 54:18-27; quiz 28-29
39. Terpenning MS, Bradley SF, Wan JY, Chenoweth CE, Jorgensen KA, Kauffman CA. Colonization and infection with antibiotic-resistant bacteria in a long-term care facility. J Am Geriatr Soc 1994; 42:1062-1069
40. Yang LP, Keam SJ. Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections. Drugs 2008; 68:855-873
41. Jacobs MR. Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children. Future Microbiol 2007; 2:591-600.
42. Odou MF, Muller C, Calvet L, Dubreuil L. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections. J Antimicrob Chemother 2007; 59:646-651
43. Cooper R. A review of the evidence for the use of topical antimicrobial agents in wound care. World Wide Wounds 2004; February:1-11. Available at http://www.worldwidewounds.com/2004/february/Cooper/Topical-Antimicrobial- Agents.html. Accessed 7 October 2009. (Pubitemid 39057793)
44. O'Meara SM, Cullum NA, Majid M, Sheldon TA. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg 2001; 88: 4-21. (Pubitemid 32066051) (Pubitemid 32066051)
45. O'Meara S, Al-Kurdi D, Ovington LG. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2008; (1):CD003557. (Pubitemid 351807485) (Pubitemid 351807485)
46. Hinchliffe RJ, Valk GD, Apelqvist J, et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 2008; 24(Suppl 1): S119-44. (Pubitemid 351802785) (Pubitemid 351802785)
47. Bergin SM, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst Rev 2006; (1): CD005082.
48. Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT. Topical silver for treating infected wounds. Cochrane Database Syst Rev 2007; (1):CD005486. (Pubitemid 351820586) (Pubitemid 351820586)
49. Jull AB, Rodgers A,Walker N. Honey as a topical treatment for wounds. Cochrane Database Syst Rev 2008; (4):CD005083.
50. Neely AN, Gardner J, Durkee P, et al. Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics? J Burn Care Res 2009; 30:19-29.